CLLKF (BICO Group AB) FCF Margin %: 12.82% (As of Mar. 2026)


CLLKF BICO Group AB CLLKF
63 GF Score
Price $1.76
GF Value $3.69
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is BICO Group AB FCF Margin %?

BICO Group AB CLLKF -7.36% 63 FCF Margin % is 12.82% as of Mar. 2026. GuruFocus rates CLLKF with a GF Score™ of 63/100 and a GF Value™ of $3.69 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, BICO Group AB ranks better than 53.25% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BICO Group AB's Free Cash Flow for the three months ended in Mar. 2026 was $4.5 Mil. BICO Group AB's Revenue for the three months ended in Mar. 2026 was $35.4 Mil. Therefore, BICO Group AB's FCF Margin % for the quarter that ended in Mar. 2026 was 12.82%.

As of today, BICO Group AB's current FCF Yield % is 1.30%.

The historical rank and industry rank for BICO Group AB's FCF Margin % or its related term are showing as below:

CLLKF' s FCF Margin % Range Over the Past 10 Years
Min: -112.6   Med: -48.9   Max: 4.21
Current: 1.11


During the past 10 years, the highest FCF Margin % of BICO Group AB was 4.21%. The lowest was -112.60%. And the median was -48.90%.

CLLKF's FCF Margin % is ranked better than
53.25% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.1 vs CLLKF: 1.11


BICO Group AB FCF Margin % Related Terms


BICO Group AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for BICO Group AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BICO Group AB FCF Margin % Chart

BICO Group AB Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -53.78 -37.67 -5.61 4.21 2.90

BICO Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.03 -10.48 -10.16 10.26 12.82

CLLKF vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, BICO Group AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BICO Group AB FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BICO Group AB's FCF Margin % falls into.


CLLKF
63GF Score
BICO Group AB CLLKF
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BICO Group AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BICO Group AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=4.67/161.102
=2.90 %

BICO Group AB's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=4.54/35.408
=12.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 12.82% mean?
BICO Group AB (CLLKF) has a FCF Margin % of 12.82% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BICO Group AB and its competitors. According to the industry distribution chart, BICO Group AB ranks #381 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 46.7%.
Is BICO Group AB's FCF Margin % too high?
BICO Group AB's current FCF Margin % is 12.82%. Based on the distribution chart, BICO Group AB ranks #381 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, BICO Group AB has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BICO Group AB's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BICO Group AB ranks #381 out of 815 companies for FCF Margin %. This puts BICO Group AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BICO Group AB and its competitors. BICO Group AB's current FCF Margin % is 12.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BICO Group AB stock overvalued right now?
Based on GuruFocus' analysis, BICO Group AB (CLLKF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.69, compared to a current price of $1.76 — trading 52.2% below its estimated fair value. The current FCF Margin % is 12.82%. BICO Group AB's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For BICO Group AB (CLLKF), the current FCF Margin % is 12.82% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BICO Group AB (CLLKF) Overvalued in 2026?

Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued. The current stock price of $1.76 is trading 52.2% below its estimated GF Value™ of $3.69. GuruFocus considers BICO Group AB to be Possible Value Trap.

Key valuation signals for CLLKF:

  • FCF Margin %: 12.82%
  • GF Value™: $3.69 vs. price of $1.76 (52.2% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the CLLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BICO Group AB Business Description

Address Grafiska vagen 2B, Gothenburg, SWE, 412 63
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
63GF Score

Get the complete analysis for CLLKF

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.76
Price
$3.69
GF Value